NCT05590936View on ClinicalTrials.gov

Dimenydrinate vs Ondansetron for PONV (DONV)

NACompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 7, 2022

Study Completion Date

December 7, 2022

Conditions
PONV in Laparoscopic Cholocystectomies
Interventions
DRUG

Dimenhydrinate Tablets

2 hours preoperative per os administration of 50 mg dimenhydrinate

DRUG

Ondansetron iv

Intraoperative intravenous administration of 4 mg ondansetron

Trial Locations (1)

Thessaly

University Hospital of Larisa, Department of Anesthesiology, Larissa

All Listed Sponsors
lead

University of Thessaly

OTHER

NCT05590936 - Dimenydrinate vs Ondansetron for PONV (DONV) | Biotech Hunter | Biotech Hunter